Cite
Maya I, Salzer Sheelo L, Brabbing-Goldstein D, et al. Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of noninvasive prenatal screening-detectable findings. Am J Obstet Gynecol. 2021;doi: 10.1016/j.ajog.2021.11.016.
Maya, I., Salzer Sheelo, L., Brabbing-Goldstein, D., Matar, R., Kahana, S., Agmon-Fishman, I., Klein, C., Gurevitch, M., Basel-Salmon, L., & Sagi-Dain, L. (2021). Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of noninvasive prenatal screening-detectable findings. American journal of obstetrics and gynecology, . https://doi.org/10.1016/j.ajog.2021.11.016
Maya, Idit, et al. "Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of noninvasive prenatal screening-detectable findings." American journal of obstetrics and gynecology vol. (2021). doi: https://doi.org/10.1016/j.ajog.2021.11.016
Maya I, Salzer Sheelo L, Brabbing-Goldstein D, Matar R, Kahana S, Agmon-Fishman I, Klein C, Gurevitch M, Basel-Salmon L, Sagi-Dain L. Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of noninvasive prenatal screening-detectable findings. Am J Obstet Gynecol. 2021 Nov 08; doi: 10.1016/j.ajog.2021.11.016. Epub 2021 Nov 08. PMID: 34762861.
Copy
Download .nbib